Paper Details

  1. Home
  2. Paper Details

Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial.

Author: BeckOlof, FranckJohan, HammarbergAnders, Jayaram-LindströmNitya

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Naltrexone was compared to placebo in reducing relapse to amphetamine use in amphetamine-dependent patients.
Paper Details　
Original Abstract of the Article :
Currently there is no approved pharmacotherapy for amphetamine dependence. Recent human laboratory studies have demonstrated that naltrexone modulates some of the reinforcing effects of amphetamine. The aim of this study was to investigate the efficacy of naltrexone in comparison with placebo in red...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1176/appi.ajp.2008.08020304

データ提供：米国国立医学図書館（NLM）

Tackling Amphetamine Dependence: A Search for Effective Treatments

The vastness of the drug addiction landscape is comparable to the endless expanse of the desert. The search for effective treatments for amphetamine dependence is a crucial endeavor. This study explores the potential of naltrexone, a medication known for its effects on opioid receptors, in reducing relapse to amphetamine use in individuals with amphetamine dependence. This research is a beacon of hope in the ongoing battle against addiction.

Naltrexone Shows Promise in Reducing Relapse

The study found that naltrexone, compared to placebo, demonstrated efficacy in reducing relapse to amphetamine use in patients with amphetamine dependence. This discovery offers a glimmer of hope in the challenging realm of addiction treatment. While more research is needed, this study suggests that naltrexone could play a valuable role in helping individuals overcome amphetamine dependence.

Harnessing the Power of Medication in Addiction Recovery

The findings of this research highlight the critical need for effective pharmacotherapy options to address amphetamine dependence. The potential of naltrexone in reducing relapse rates opens new avenues for treatment and provides a valuable tool for healthcare professionals working on the front lines of addiction recovery.

Dr.Camel's Conclusion

The search for effective treatments for amphetamine dependence is a long and winding journey, much like traversing the vast desert. This study sheds light on the potential of naltrexone as a promising treatment option. The results underscore the importance of continued research and development of pharmacotherapies to address the complex challenges of addiction.
Date :
  1. Date Completed 2008-11-18
  2. Date Revised 2014-11-20
Further Info :

Pubmed ID

18765480

DOI: Digital Object Identifier

10.1176/appi.ajp.2008.08020304

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.